Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
DCFirst Claim
Patent Images
1. An oral dosage form in the form of a capsule which comprises:
- 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition;
2) a binder or filler at an amount of 90 to 99 weight percent of total weight of the composition, wherein the binder or filler is a mixture of starch and mannitol; and
wherein the ratio of mannitol;
starch in the dosage form is from about 1;
1 to about 1;
1.5.
1 Assignment
Litigations
0 Petitions
Accused Products
Abstract
Pharmaceutical compositions and single unit dosage forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, or a pharmaceutically acceptable stereoisomer, prodrug, salt, solvate, hydrate, or clathrate, are provided herein. Also provided are methods of treating, managing, or preventing various disorders, such as cancer or an inflammatory disease.
-
Citations
8 Claims
-
1. An oral dosage form in the form of a capsule which comprises:
- 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition;
2) a binder or filler at an amount of 90 to 99 weight percent of total weight of the composition, wherein the binder or filler is a mixture of starch and mannitol; andwherein the ratio of mannitol;
starch in the dosage form is from about 1;
1 to about 1;
1.5. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- 1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition;
Specification